Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder

Multiple Sclerosis and Related Disorders

Volumn 7, Issue , 2016, Pages 53-57

  Yoshii, Fumihito ^a   Moriya, Yusuke ^a   Ohnuki, Tomohide ^a   Ryo, Masafuchi ^a   Takahashi, Wakoh ^a  

^a TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

Author keywords

Fingolimod; Leukoencephalopathy; MRI; Multiple sclerosis; Neuromyelitis optica spectrum disorder

Indexed keywords

AQUAPORIN 4 ANTIBODY; BETA1 INTERFERON; CORTICOSTEROID; FINGOLIMOD; GADOLINIUM; METHYLPREDNISOLONE; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBODY DETECTION; ARTICLE; BACKACHE; CASE REPORT; CHEST PARESTHESIA; DIPLOPIA; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FEMALE; HAND PARESTHESIA; HUMAN; LEG PARESTHESIA; LEUKOENCEPHALOPATHY; LYMPHOCYTE COUNT; MONOTHERAPY; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARESTHESIA; RELAPSE; REMISSION; SPINAL CORD LESION; THORAX PAIN; BRAIN; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; IMMUNOLOGY; MIDDLE AGED; NEUROMYELITIS OPTICA; SPINAL CORD;

AQUAPORIN 4; BRAIN; FEMALE; FINGOLIMOD HYDROCHLORIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROMYELITIS OPTICA; SPINAL CORD;

EID: 84961821990     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2016.03.004     Document Type: Article

References (5)

1. J. Kira, Y. Itoyama, S. Kikuchi, and et al. Fingolomod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: result of a phase 2 observational extension BMC Neurol. 14 2014 21 10.1186/1471-2377-14-21
2. T. Saida, S. Kikuchi, Y. Itoyama, and et al. A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis Mult. Scler. 18 2012 1269 1277
3. J.H. Min, B.J. Kim, and K.H. Lee Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder Mult. Scler. 18 2012 113 115
4. S. Izaki, S. Narukawa, A. Kubota, and et al. A case of neuromyelitis optica spectrum disorder developing a fulminant course with multiple white-matter lesions following fingolimod treatment Clin. Neurol. 53 2013 513 517
5. M. Tanaka, M. Oono, R. Motoyama, and et al. Longitudinally extensive spinal cord lesion after initiation, and multiple extensive brain lesions after cessation of fingolimod treatment in a patient with recurrent myelitis and anti-aquaporin 4 antibodies Clin. Exp. Neuroimmunol. 4 2013 239 240